CICALESE, MARIA PIA
 Distribuzione geografica
Continente #
EU - Europa 826
AS - Asia 751
NA - Nord America 653
SA - Sud America 73
AF - Africa 14
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 2.330
Nazione #
US - Stati Uniti d'America 636
CN - Cina 290
SE - Svezia 275
SG - Singapore 273
IT - Italia 236
HK - Hong Kong 116
RU - Federazione Russa 88
DE - Germania 80
BR - Brasile 57
AT - Austria 34
GB - Regno Unito 32
IN - India 27
FI - Finlandia 22
NL - Olanda 18
CA - Canada 12
ES - Italia 11
IE - Irlanda 10
IQ - Iraq 10
IR - Iran 8
AU - Australia 7
JP - Giappone 7
PE - Perù 6
ET - Etiopia 5
FR - Francia 5
MX - Messico 5
TR - Turchia 5
BE - Belgio 4
BG - Bulgaria 4
DZ - Algeria 4
EU - Europa 4
KR - Corea 4
LT - Lituania 4
AR - Argentina 3
IL - Israele 3
ID - Indonesia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PS - Palestinian Territory 2
VE - Venezuela 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
EG - Egitto 1
KE - Kenya 1
MK - Macedonia 1
ML - Mali 1
NG - Nigeria 1
NP - Nepal 1
PY - Paraguay 1
UY - Uruguay 1
Totale 2.330
Città #
Shanghai 180
Singapore 121
Hong Kong 114
Lawrence 78
Princeton 78
New York 76
Milan 75
Moscow 43
Ashburn 33
Boardman 32
Nuremberg 30
Rome 25
Helsinki 19
Cesano Boscone 18
Vienna 17
Brescia 16
Guangzhou 14
London 14
Pune 10
Shenzhen 10
Monza 9
Seattle 9
Dublin 8
Falkenstein 7
Los Angeles 7
Amsterdam 6
Lima 6
Turin 6
Washington 6
Aksum 5
Beijing 5
Brisbane 5
Cambridge 5
Dallas 5
Frankfurt am Main 5
Hillah 5
Madrid 5
Santa Clara 5
Bengaluru 4
Chevy Chase 4
Chicago 4
Delhi 4
Florence 4
Hamburg 4
Hangzhou 4
Michaelnbach 4
Ottawa 4
Perugia 4
Philadelphia 4
Rio de Janeiro 4
São Paulo 4
Verona 4
Algiers 3
Ankara 3
Badalona 3
Barcelona 3
Bethesda 3
Bologna 3
Brussels 3
Cagliari 3
Gijang-gun 3
Harbor Springs 3
Kassel 3
Lappeenranta 3
Loughton 3
Moorestown 3
Paris 3
Park City 3
Parma 3
Reston 3
St Petersburg 3
Stockholm 3
Tokyo 3
Wuxi 3
Athlone 2
Aurora 2
Belo Horizonte 2
Berlin 2
Brooklyn 2
Bursa 2
Campobasso 2
Cherry Hill 2
Council Bluffs 2
Dayton 2
Daytona Beach 2
Duhok 2
Düsseldorf 2
Falconara Marittima 2
Farmington 2
Goiânia 2
Gustavo Adolfo Madero 2
Hamilton 2
Heidelberg 2
Hyderabad 2
Jiaxing 2
Kingston upon Thames 2
Las Vegas 2
Laurel 2
Linköping 2
Malnate 2
Totale 1.286
Nome #
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy 257
Reduced PD-1 expression on circulating follicular and conventional FOXP3+ Treg cells in children with new onset type 1 diabetes and autoantibody-positive at-risk children 59
Case Report: Consistent disease manifestations with a staggered time course in two identical twins affected by adenosine deaminase 2 deficiency 58
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access 55
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 41
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 41
Hematopoietic stem-and progenitor-cell gene therapy for hurler syndrome 39
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 38
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency 36
Wiskott–Aldrich syndrome: Oral findings and microbiota in children and review of the literature 36
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 35
Peripheral blood stem and progenitor cell collection in pediatric candidates for ex vivo gene therapy: a 10-year series 35
Follicular helper T cell signature of replicative exhaustion, apoptosis and senescence in common variable immunodeficiency 35
Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy 34
Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency 32
ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation 32
COVID-19 in recipients of allogeneic stem cell transplantation: favorable outcome 32
B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients 31
A combined immunodeficiency with severe infections, inflammation, and allergy caused by ARPC1B deficiency 31
A novel genomic inversion in Wiskott-Aldrich-associated autoinflammation 29
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 29
Corrigendum: Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies 29
Urogenital Abnormalities in Adenosine Deaminase Deficiency 29
The EHA Research Roadmap: Hematopoietic Stem Cell Gene Therapy 29
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome 28
A Case of Two Adult Brothers with Wiskott-Aldrich Syndrome, One Treated with Gene Therapy and One with HLA-Identical Hematopoietic Stem Cell Transplantation 28
Hematopoietic reconstitution dynamics of mobilized- and bone marrow-derived human hematopoietic stem cells after gene therapy 27
Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients (Journal of Clinical Immunology, (2021), 41, 7, (1633-1647), 10.1007/s10875-021-01098-0) 27
Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit 27
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 27
Pioglitazone as a novel therapeutic approach in chronic granulomatous disease 27
Mild SARS-CoV-2 Infection After Gene Therapy in a Child With Wiskott-Aldrich Syndrome: A Case Report 27
A Prevalent CXCR3+ Phenotype of Circulating Follicular Helper T Cells Indicates Humoral Dysregulation in Children with Down Syndrome 27
T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency 27
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 26
Treatment with rapamycin can restore regulatory T-cell function in IPEX patients 26
Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated BCGitis 26
Abnormalities of acid-base balance and predisposition to metabolic acidosis in Metachromatic Leukodystrophy patients 25
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. 25
Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease 25
Correction to: A Case of Two Adult Brothers with Wiskott‑Aldrich Syndrome, One Treated with Gene Therapy and One with HLA‑Identical Hematopoietic Stem Cell Transplantation (Journal of Clinical Immunology, (2022), 42, 2, (421-425), 10.1007/s10875-021-01157-6) 24
NADPH Oxidase Deficiency: A Multisystem Approach 24
Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: Change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response 24
Editorial: Follicular Helper T Cells in Immunity and Autoimmunity 24
Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset 24
Up to 10.5 Years of Follow-Up in 17 Subjects Treated with Hematopoietic Stem and Progenitor Cell Lentiviral Gene Therapy for Wiskott-Aldrich Syndrome 23
Clinical, immunological, and molecular features of typical and atypical severe combined immunodeficiency: Report of the italian primary immunodeficiency network 23
Purine metabolism, immune reconstitution, and abdominal adipose tumor after gene therapy for adenosine deaminase deficiency 22
Circulating follicular helper and follicular regulatory T cells are severely compromised in human CD40 deficiency: A case report 22
EFFICACY OF THE ANDRESEN ACTIVATOR BEFORE PEAK GROWTH IN CLASS II PATIENTS 22
Telemedicine in myocarditis: Evolution of a mutidisciplinary “disease unit” at the time of COVID-19 pandemic 22
Immunosuppressive therapy in childhood‐onset arrhythmogenic inflammatory cardiomyopathy 22
Reduced Follicular Regulatory T Cells in Spleen and Pancreatic Lymph Nodes of Patients With Type 1 Diabetes 22
Beta2 integrins are required for follicular helper T cell differentiation in humans 22
Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β 22
Gene therapy in rare diseases: The benefits and challenges of developing a patient-centric registry for Strimvelis in ADA-SCID 21
Dynamics of genetically engineered hematopoietic stem and progenitor cells after autologous transplantation in humans 21
Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study 21
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 21
Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity 21
Clinical applications of gene therapy for primary immunodeficiencies 20
Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy 20
Central venous access devices in pediatric malignancies: a position paper of Italian Association of Pediatric Hematology and Oncology 20
Human IL2RA null mutation mediates immunodeficiency with lymphoproliferation and autoimmunity 19
In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases 19
Neutrophils drive type-I interferon production and autoantibodies in Wiskott-Aldrich syndrome 19
Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients 19
Successful use of long-acting octreotide for intractable chronic gastrointestinal bleeding in children 18
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial 18
Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies 18
SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity 17
LENTIVIRAL VECTOR TRANSDUCED CD34+CELLS FOR THE TREATMENT OF WISKOTT-ALDRICH SYNDROME 17
T regulatory cell therapy in preclinical and clinical pancreatic islet transplantation 16
Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy 16
Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP) 16
Relationship between severe obesity and gut inflammation in children: what’s next? 15
Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case report 14
Lentiviral gene therapy corrects platelet phenotype and function in Wiskott-Aldrich patients 14
New perspectives in gene therapy for inherited disorders 14
Successful Treatment With Ledipasvir/Sofosbuvir in an Infant With Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency With HCV Allowed Gene Therapy with Strimvelis 14
Risk of seizures in children receiving busulphan-containing regimens for stem cell transplantation 14
CXCR5-CXCL13 axis markers in full-term and preterm human neonates in the first weeks of life 14
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 14
La mucosite post-chemioterapia in bambini sottoposti a terapia genica, l'esperienza del San Raffaele di Milano 13
Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD 13
Gene Therapy for Adenosine Deaminase Deficiency: A Comprehensive Evaluation of Short- and Medium-Term Safety 13
First occurrence of plasmablastic lymphoma in adenosine deaminase-deficient severe combined immunodeficiency disease patient and review of the literature 13
Requesting iodine supplementation in children on parenteral nutrition 13
Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer 13
Intergenerational and intrafamilial phenotypic variability in 22q11.2 deletion syndrome subjects 13
Gene therapy trial with lentiviral vector transduced CD34+cells for the treatment of Wiskott-Aldrich Syndrome 12
Treatment of chronic hepatitis C in children with pegylated interferon and ribavirin : the impact of dose 12
Management of autoimmune hepatitis in children: how many steps away from common agreement? 12
NFKB2 regulates human Tfh and Tfr pool formation and germinal center potential 10
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 9
Efficacy and safety of an amino-acid-based formula during the period of weaning children with intestinal failure and parenteral nutrition 8
null 1
Totale 2.514
Categoria #
all - tutte 27.611
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.611


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 0 0 13 0 0
2020/202119 0 1 0 1 6 7 3 0 0 1 0 0
2021/202286 0 0 1 13 6 3 8 9 33 4 6 3
2022/2023588 171 113 47 4 11 67 18 56 37 15 27 22
2023/2024604 47 33 59 69 47 100 29 43 5 28 25 119
2024/20251.152 161 42 66 75 76 130 214 227 161 0 0 0
Totale 2.514